APA (7th ed.) Citation

Sasipong, N., Schlegel, P., Wingert, J., Lederer, C., Meinhardt, E., Ziefer, A., . . . Raake, P. (2021). Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction. Molecular therapy, 29(8), . https://doi.org/10.1016/j.ymthe.2021.04.010

Chicago Style (17th ed.) Citation

Sasipong, Nuttarak, et al. "Ligand-activated RXFP1 Gene Therapy Ameliorates Pressure Overload-induced Cardiac Dysfunction." Molecular Therapy 29, no. 8 (2021). https://doi.org/10.1016/j.ymthe.2021.04.010.

MLA (9th ed.) Citation

Sasipong, Nuttarak, et al. "Ligand-activated RXFP1 Gene Therapy Ameliorates Pressure Overload-induced Cardiac Dysfunction." Molecular Therapy, vol. 29, no. 8, 2021, https://doi.org/10.1016/j.ymthe.2021.04.010.